14 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Pain Medication Dosing ... based on GFR ... #Renal #Dosing # ... Pain #Pharmacology ... #Opiates #CKD #
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Patients With Type 2 Diabetes ... 3A, 3B, or 4 Diabetes ... #Metformin #CKD3 ... #CKD4 #Dosing # ... Pharmacology #VisualAbstract
Algorithm for Metformin Prescribing and Dosing in CKD
Dose Initiation - Immediate release:
 • Initial 500 mg
Prescribing and Dosing ... in CKD Dose Initiation ... #Prescribing #Dosing ... #CKD #pharmacology ... #algorithm #diabetes
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
: Weight-Based Dosing ... (stage IV or V CKD ... #TDD #Insulin #dosing ... Weight #Based #pharmacology ... endocrinology #diabetes
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... Patients With CKD ... and CKD should ... evidence-based pharmacologic ... #Diabetes #CKD #
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
The optimal TTR ... #management #algorithm ... #pharmacology # ... hematology #warfarin #dosing
Metformin in Diabetic Kidney Disease
Immediate release:
 • Initial 500 mg or 850 mg once daily
 •
Metformin in Diabetic ... #Metformin #CKD ... #pharmacology # ... algorithm #management
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... Inhibitors #Renal #Dosing ... #Pharmacology # ... Management #Diabetes
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
oral suspension DOSING ... patients with CKD ... , HF, or diabetes ... #Hyperkalemia #Pharmacology